MISTR Celebrates a Historic Achievement in Patient Care
MISTR has crossed an impressive threshold, now serving over 500,000 patients across the nation. This accomplishment highlights the company's ongoing dedication to providing vital services such as free online STI testing, PrEP, DoxyPEP, and comprehensive HIV care. By addressing the demand for accessible healthcare, MISTR is leading the way to support historically underserved communities without any cost barriers.
Addressing Public Health Concerns
The importance of MISTR's work is underscored by the alarming public health landscape, characterized by escalating rates of sexually transmitted infections. In recent statistics, more than 2.4 million cases of syphilis, gonorrhea, and chlamydia have been reported, further emphasizing the need for proactive healthcare measures. Since DoxyPEP became available to the public in 2022, healthcare providers have experienced remarkable reductions in bacterial STI diagnoses, with reports indicating decreases of 50% in some areas.
Success with DoxyPEP
Since its launch in April 2024, MISTR has seen an overwhelming response to DoxyPEP, with a staggering 74% of participating patients requesting this preventative medication. The positive impact is also evident in the STI positivity rate among MISTR patients, which dropped from 12.42% to 6.16% following the availability of DoxyPEP. This drastic change showcases MISTR’s pivotal contribution to enhancing sexual health and reducing STI rates across the United States.
Community Partnerships and Future Goals
MISTR's recent collaboration with Walmart in Georgia highlights its commitment to expanding outreach and accessibility. By providing free test kits at various locations, the company aims to address the growing rate of HIV/STIs in the area directly. Looking ahead to 2025, MISTR is focused on forging further partnerships and enhancing its presence in major locations such as West Hollywood, New York City, San Francisco, Chicago, Dallas, and Wilton Manors.
Leadership Insight
Tristan Schukraft, the Founder and CEO of MISTR, reflects on this significant milestone with pride. He emphasizes the teamwork and community dedication behind this achievement, recognizing the urgency of stopping HIV transmission and promoting safer sexual practices. His personal connection to the cause resonates deeply within the mission of MISTR, as he champions the health and future well-being of generations to come.
About MISTR
MISTR stands as the largest telemedicine platform offering free, online access to pre-exposure prophylaxis (PrEP) and long-term HIV care, covering all 50 states, including D.C. and Puerto Rico. Being a gay-owned and operated service, MISTR has assembled an exceptional network of healthcare professionals, which includes doctors and pharmacists, to enhance access to essential health services like PrEP, DoxyPEP, and HIV care. The process is hassle-free, eliminating the need for doctor's appointments or paperwork and providing free medication delivery straight to those in need.
Frequently Asked Questions
What services does MISTR provide?
MISTR offers free online STI testing, PrEP, DoxyPEP, and long-term HIV care to patients across the United States.
How has DoxyPEP impacted STI rates?
DoxyPEP has led to a remarkable 50% reduction in bacterial STI diagnoses among users since its introduction.
What is MISTR's mission?
MISTR aims to promote accessible healthcare solutions to enhance sexual health, particularly for historically underserved communities.
How is MISTR expanding its services?
MISTR is forging significant partnerships, such as with Walmart, to enhance testing access and combat rising HIV/STI rates.
Who is the founder of MISTR?
Tristan Schukraft is the Founder and CEO of MISTR, dedicated to improving sexual health and community well-being.
